V10153

Vernalis (R&D) Ltd · Phase 2 active Small molecule

At a glance

Generic name	V10153
Also known as	Code Names: V10153, BB-10153, CAS Registry Number: 931101-84-7, Proposed INN: Troplasminogen alfa
Sponsor	Vernalis (R&D) Ltd
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy Study in Acute Ischaemic Stroke (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

V10153 CI brief — competitive landscape report
V10153 updates RSS · CI watch RSS
Vernalis (R&D) Ltd portfolio CI